Skip Nav Destination
Issues
ORIGINAL ARTICLES
Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy—Phase 2 Trial Secondary Analysis
Robert H. Press, MD; Joseph W. Shelton, MD; Chao Zhang, PhD; Quang Dang, CMD; Sibo Tian, MD; Timothy Shu, MPH; Crystal S. Seldon, MD; Shaakir Hasan, DO; Ashesh B. Jani, MD, FASTRO; Jun Zhou, PhD; Mark W. McDonald, MD
Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
James E. Bates, MD; Stephanie Terezakis, MD; Christopher G. Morris, MS; Avani D. Rao, MD; Shuchi Sehgal, BA; Rahul Kumar, MBBS; Raymond B. Mailhot Vega, MD, MPH; Nancy P. Mendenhall, MD; Bradford S. Hoppe, MD, MPH
Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients
Natalie A. Lockney, MD; Randal H. Henderson, MD, MBA; Steven G. Swarts, PhD; Zhenhuan Zhang, MD, PhD; Bingrong Zhang, DVM, MD; Jennifer Li, BS; Robert A. Zlotecki, MD, PhD; Christopher G. Morris, MS; Katherine A. Casey-Sawicki, MA;; Paul G. Okunieff, MD
Insurance Approval for Definitive Proton Therapy for Prostate Cancer
William M. Mendenhall, MD; Eric D. Brooks, MD, MHS; Stephanie Smith; Christopher G. Morris, MS; Curtis B. Bryant, MD, MPH; Randal H. Henderson, MD; Romaine C. Nichols, Jr., MD; Kathy McIntyre; Stuart L. Klein, MHA; Nancy P. Mendenhall, MD
EDITORIAL
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
Raymond B. Mailhot Vega, MD, MPH; Sharon M. Castellino, MD, MSc; Qinglin Pei, PhD; Susan Parsons, MD MRP; Kenneth B. Roberts, MD; David Hodgson, MD, MPH; Anne-Marie Charpentier, MD; Thomas J. Fitzgerald, MD; Sandy K. Kessel; Frank G. Keller; Kara Kelly, MD; Bradford S. Hoppe, MD, MPH
CASE REPORTS
Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma
Vidya Puthenpura, MD; Nicholas J. DeNunzio, MD, PhD; Xue Zeng, PhD; Drosoula Giantsoudi, PhD; Mariam Aboian, MD, PhD; David Ebb, MD; Kristopher T. Kahle, MD, PhD; Torunn I. Yock, MD; Asher M. Marks, MD
-
Cover Image
Cover Image
Get Email Alerts
Strategic Operational Redesign Improves Prior Authorization Access: A Validation Study
Eric D. Brooks, MD, MHS, Fantine Giap, MD, Vincent Cassidy, MD, Matthew S. Ning, MD, MPH, Bradlee Robbert, FACHE, MHA, RT(R)(T), Polly Redding, MBS, CPC, CHONC, Matthew Palmer, MBA, L. Montreal Turner, MBA, MHA, CMD, PMP, William M. Mendenhall, MD, Stuart Klein, MHA, Nancy P. Mendenhall, MD
Cognition and Brain System Segregation in Pediatric Brain Tumor Patients Treated with Proton Therapy
Anna V. Dowling, BS, Benjamin A. Seitzman, PhD, Timothy J. Mitchell, PhD, Michael Olufawo, BS, Donna L. Dierker, BS, Hari Anandarajah, BS, Ally Dworetsky, BS, Alana McMichael, MA, Catherine Jiang, BS, Dennis L. Barbour, MD, PhD, Bradley L. Schlaggar, MD, PhD, David D. Limbrick, MD, PhD, Jennifer M. Strahle, MD, Joshua B. Rubin, MD, PhD, Joshua S. Shimony, MD, PhD, Stephanie M. Perkins, MD
Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom
Hunter Mehrens, MS, Paige Taylor, MS, Paola Alvarez, MS, Stephen Kry, PhD
Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
Alicia Bao, BS, Andrew R. Barsky, MD, Stefan Both, PhD, John P. Christodouleas, MD, MPH, Curtiland Deville, Jr, MD, Zelig A. Tochner, MD, Neha Vapiwala, MD, Russell Maxwell, MD
Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review
Jonathan S. Fakhry, M. Juliana Pena, Ariel Pomputius, Fantine Giap, MD, Raymond B. Mailhot Vega, MD